ARCHIVES

The Clinical Cancer Letter To End Print Edition In 2010

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

Senate Report Calls on NCI To Expand Research in Survivorship, CAM, GYN Cancers, And Fund Five Pancreatic SPOREs

August 2, 2002

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

In Congress: Senate Bill Offers 13% Increase For NCI; house Provides 9%

October 8, 1999

Cancer Control Emphasis Shift to Prevention Projected For Y 1978; Advisors Seek More

July 29, 1977

ACS Recommends MRI For Some Women At High Risk

March 30, 2007

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

June 11, 1993